Catheter Precision terminates ATM equity facility after selling ~$4.0M of $4.3M

Catheter Precision, Inc.

Terminated ATM agreement with Ladenburg Thalmann effective November 24, 2025; no penalties.
Prior to termination, $4.0M of common stock sold under the $4.3M capacity.
Remaining $0.3M of at-the-market offering capacity is no longer available.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Catheter Precision, Inc. terminated At-Market-Offering Agreement with Ladenburg Thalmann & Co. Inc. (effective 2025-11-17).

Action: termination
Agreement: atm program
Counterparty: Ladenburg Thalmann & Co. Inc.
Effective: 2025-11-17

Exact text from the filing

On November 17, 2025, Catheter Precision, Inc. (the “Company”) delivered notice to terminate its At-Market-Offering Agreement (the “ATM Agreement”), dated as of May 19, 2025, with Ladenburg Thalmann & Co. Inc. (the “Agent”) providing for the Company’s “at‐the‐market” equity offering program (the “ATM Program”), to be effective as of November 24, 2025.

View on SEC.gov

Browse all material agreements →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-036000

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.